1. ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase
- Author
-
Thomas Weber, Susan L. Ackerman, Litao Sun, Bappaditya Roy, Qi Liu, Paul Schimmel, Markus Terrey, My-Nuong Vo, Hongjun Fu, John R. Yates, Jeong Woong Lee, Kurt Fredrick, and James J. Moresco
- Subjects
0301 basic medicine ,Mutation ,Multidisciplinary ,Positional cloning ,Aminoacyl tRNA synthetase ,Mutant ,Protein aggregation ,medicine.disease_cause ,Cell biology ,Serine ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,chemistry ,Transfer RNA ,medicine ,Ankyrin repeat - Abstract
Editing domains of aminoacyl tRNA synthetases correct tRNA charging errors to maintain translational fidelity. A mutation in the editing domain of alanyl tRNA synthetase (AlaRS) in Aars sti mutant mice results in an increase in the production of serine-mischarged tRNAAla and the degeneration of cerebellar Purkinje cells. Here, using positional cloning, we identified Ankrd16, a gene that acts epistatically with the Aars sti mutation to attenuate neurodegeneration. ANKRD16, a vertebrate-specific protein that contains ankyrin repeats, binds directly to the catalytic domain of AlaRS. Serine that is misactivated by AlaRS is captured by the lysine side chains of ANKRD16, which prevents the charging of serine adenylates to tRNAAla and precludes serine misincorporation in nascent peptides. The deletion of Ankrd16 in the brains of Aarssti/sti mice causes widespread protein aggregation and neuron loss. These results identify an amino-acid-accepting co-regulator of tRNA synthetase editing as a new layer of the machinery that is essential to the prevention of severe pathologies that arise from defects in editing.
- Published
- 2018
- Full Text
- View/download PDF